Simon Frantz. Show Affiliations »
Abstract
Mesh： See more » Anti-Inflammatory Agents, Non-Steroidal/adverse effectsAnti-Inflammatory Agents, Non-Steroidal/therapeutic useCerebral Infarction/etiologyClinical Trials as TopicCyclooxygenase Inhibitors/adverse effectsCyclooxygenase Inhibitors/therapeutic useDrug IndustryDrug Monitoring/methodsDrug Monitoring/standardsDrug Monitoring/trendsFederal GovernmentForecastingHumansLactones/adverse effectsLactones/therapeutic useMyocardial Infarction/etiologyProduct Surveillance, Postmarketing/methodsProduct Surveillance, Postmarketing/standardsRiskSulfones/adverse effectsSulfones/therapeutic useTime FactorsUnited StatesUnited States Food and Drug Administration
Substances： See more » Anti-Inflammatory Agents, Non-SteroidalCyclooxygenase InhibitorsLactonesSulfonesrofecoxib
Year: 2005 PMID： 15690595 DOI： 10.1038/nrd1629
Source DB: PubMed Journal: Nat Rev Drug Discov ISSN： 1474-1776 Impact factor: 84.694